James E. Flynn

Holdings History for BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

Symbol: BCRX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 14,341,000 shares
Security Ownership %: 6.8%

Deerfield Mgmt, L.P. ownership in BIOCRYST PHARMACEUTICALS INC Common Stock (BCRX)

12 Feb 2026 - Deerfield Mgmt, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 14,341,000 shares of BIOCRYST PHARMACEUTICALS INC Common Stock (BCRX). This represents 6.8% ownership of the company. In their previous filing dated 19 Sep 2025, James E. Flynn had reported owning 12,169,000 shares, indicating an increase of +18%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Deerfield Mgmt, L.P.	6.8%	+17%	$109,278,420	14,341,000	+2,172,000	+18%	$7.62	13G/A	31 Dec 2025	12 Feb 2026, 14:17
Deerfield Mgmt, L.P.	5.8%		$103,071,430	12,169,000			$8.47	13G	12 Sep 2025	19 Sep 2025, 12:23